CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 891 - 900 of 926
Study Number Lead Group Study Title CIRB Study Status
UAZ2016-08-02 CLO-University of Arizona A feasibility trial of alternating intravaginal application of 5-fluorouracil and imiquimod for treatment of high-grade cervical squamous intraepithelial lesions Cancer Prevention and Control CIRB Available to Open
URCC-18007 NCORP-University of Rochester Cancer Center Randomized Placebo-Controlled Trial of Bupropion for Cancer-Related Fatigue Cancer Prevention and Control CIRB Available to Open
EAQ161CD ECOG-ACRIN Biomarker Testing in Common Solid Cancers: An Assessment of Current Practices in Precision Oncology in the Community Setting Cancer Prevention and Control CIRB Completed
EAQ202 ECOG-ACRIN Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials Cancer Prevention and Control CIRB Available to Open
A222001 Alliance A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Oxybutynin Versus Placebo for the Treatment of Hot Flashes in Men Receiving Androgen Deprivation Therapy Cancer Prevention and Control CIRB Available to Open
A221505 Alliance RT Charm: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation with Breast Reconstruction Cancer Prevention and Control CIRB Available to Open
NWU2015-06-03 CLO-Northwestern University Statin Therapy to Reduce Disease Progression from Liver Cirrhosis to Cancer Cancer Prevention and Control CIRB Available to Open
UWI2015-05-01 CLO-University of Wisconsin Phase Ib 9cUAB30 in Early Stage Breast Cancer to Evaluate Biologic Effect Cancer Prevention and Control CIRB Available to Open
MAY2015-05-01 CLO-Mayo Clinic Randomized, double-blind, placebo-controlled trial of Meriva® (curcuminoids) as a candidate chemoprevention agent for gastric carcinogenesis Cancer Prevention and Control CIRB Available to Open
NRG-CC007CD NRG Increasing the Dose of Survivorship Care Planning in Prostate Cancer Survivors Who Receive Androgen Deprivation Therapy Cancer Prevention and Control CIRB Available to Open
Displaying 891 - 900 of 926